Pathological flow-induced endothelial damage and plaque erosion
病理性血流诱导的内皮损伤和斑块侵蚀
基本信息
- 批准号:9974575
- 负责人:
- 金额:$ 79.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-15 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAnimal ModelApoptosisAreaArterial Fatty StreakBindingBlood flowCell AgingCell ProliferationChemicalsComplexDataDevelopmentEdemaEndothelial CellsEndotheliumEventFeedbackFibrinFibrinogenFunctional disorderGoalsHemorrhageHigh Fat DietHomologous GeneIn VitroInflammationInjectionsKnock-in MouseKnock-outLATS1 geneLasersLesionLinkMAPK7 geneMechanicsMediatingMolecularMusNecrosisOutcomePathologicPathologyPathway interactionsPhenotypePhosphorylationPhosphotransferasesPhysiologicalPlayProcessProteinsResearchRoleRuptureSignal PathwaySignal TransductionSudden DeathTERF2 geneTamoxifenTestingThromboplastinThrombusTimeTumor Suppressor ProteinsWorkaortic archatherosclerosis riskbasecell injurycoronary eventhigh riskhypercholesterolemiainnovationinsightnovel strategiesnovel therapeutic interventionpreventprotein degradationsenescenceshear stresstelomeretheoriestranscription factorubiquitin-protein ligase
项目摘要
Project Summary/Abstract
Atherosclerotic and high-risk plaques including both rupture and erosion are predominantly localized to vessel
wall regions with non-laminar disturbed blood flow (d-flow) and laminar high flow (h-flow). However, the
molecular mechanisms of this pathological flow-induced high-risk plaque remain largely unknown mainly
because of the lack of such high-risk plaque animal models, hence there is an urgent need to correct this gap.
Our long-term goal is to determine how the high-risk plaque is formed by pathological flow. We found that
within 14 days after inducing LATS (large tumor suppressor homolog) 1/2 deletion in tamoxifen-inducible
endothelial cell (EC) specific LATS1homo/LATS2homoknock-out mice (LATS1homo/LATS2homo-EKO), all mice
(28/28) died of severe systemic edema, accompanied by massive EC apoptosis. Next we generated EC-
specific LATS1het/LATS2homo-EKO hypercholesteremic (H-chol) mice; we detected a plaque erosion-like lesions
at h- and d-flow areas in the aortic arch and carotids, which revealed strong fibrin/fibrinogen positive organized
thrombus formation without a large necrotic core. We observed significant increases in 1) EC proliferation, 2)
EC apoptosis with senescent phenotype, 3) tissue factor (TF) expression, and 4) inflammation, which are
collectively referred to as the “pro-thrombotic phenotype”. We hypothesize that pathological flow-induced
LATS1/2 degradation promotes EC damage-mediated thrombus formation and luminal re-endothelialization in
concert. This cycle of EC damage-thrombus-re-endothelialization results in largethrombus formation and
plaque erosion. Pathological flow-induced MAGI1 S741 phosphorylation by PKC, and the subsequent
LATS1/2-TERF2IP-MKRN1 complex formation are essential for LATS1/2 degradation. To test ths hypothesis,
we propose the following 3 aims. In aim 1, we will characterize the role of excess EC proliferation,
senescence/apoptosis, tissue factor (TF) expression, and inflammation in the formation of plaque erosion-like
lesions and intraplaque hemorrhage in EC specific Lats1het/Lats2homo knock-out (Lats1het/Lats2homo-EKO) mice
under H-chol. In aim 2, we will determine the crucial role of phosphorylation dependent TERF2IP and MKRN1
Ub E3 ligase binding in pathological flow-induced LATS1/2 destabilization and the consequent pro-thrombotic
phenotype, and in aim 3 we will Investigate the role of PKC-induced MAGI1 S741 phosphorylation in
LATS1/2-mediated TERF2IP S205 phosphorylation and LATS1/2 degradation. The proposed work is expected
to establish the link between pathological flow and pro-thrombotic phenotype, by which high-risk plaques are
formed. The proposed study is innovative because it will propose a new concept how pathological flow affects
the endothelium and induce the formation of vulnerable plaques of erosion and will provide insights into new
signaling cascades and molecules responsible for this pathology. The proposed research may also provide
means to predict and prevent high-risk plaque formation.
项目摘要/摘要
包括破裂和侵蚀在内的动脉粥样硬化和高风险斑块主要局限于血管
具有非晶状体干扰血流(D-Flow)和层流高流量(H-Flow)的壁区。但是,
这种病理流动引起的高风险斑块的分子机制主要未知
由于缺乏如此高风险的斑块动物模型,因此迫切需要纠正这一差距。
我们的长期目标是确定如何通过病理流动形成高风险牌匾。我们发现
在诱导LATS(大肿瘤抑制剂同源物)1/2缺失后14天内
内皮细胞(EC)特定的LATS1HOMO/LATS2HOMOKNOCK-OUT小鼠(LATS1HOMO/LATS2HOMO-EKO),所有小鼠
(28/28)死于严重的全身水肿,通过大量EC凋亡完成。接下来,我们产生了
特定的LATS1HET/LATS2HOMO-EKO高胆固醇(H-Chol)小鼠;我们检测到牙菌斑状的病变
在主动脉弓和颈动脉中的H和D流动区域,揭示了强烈的纤维蛋白/纤维蛋白原积极组织
血栓形成没有大坏死核。我们观察到1)EC增殖的显着增加,2)
具有感觉表型的EC凋亡,3)组织因子(TF)表达和4)炎症,这是
统称为“亲栓性表型”。我们假设病理流动诱导
LATS1/2降解促进了EC损伤介导的血栓形成和腔内皮层化。
音乐会。 EC损伤 - 肉瘤 - 重新皮层化的这一周期导致形成大量的甲基曲霉和
斑块侵蚀。病理流动诱导的MAGI1 S741磷酸化,随后的
LATS1/2-TERF2IP-MKRN1复合物形成对于LATS1/2降解至关重要。为了检验假设,
我们提出以下3个目标。在AIM 1中,我们将表征超过EC增殖的作用,
在形成斑块样形成中的感应/凋亡,组织因子(TF)表达和炎症
EC特异性LATS1HET/LATS2HOMO敲除(LATS1HET/LATS2HOMO-EKO)小鼠的病变和内部出血
在H-Chol下。在AIM 2中,我们将确定磷酸化依赖性TERF2IP和MKRN1的关键作用
病理流动诱导的LATS1/2不稳定的UB E3连接酶结合,随之而来的促脉症
表型,在AIM 3中,我们将研究PKC诱导的MAGI1 S741磷酸化在
LATS1/2介导的TERF2IP S205光态和LATS1/2降解。预计拟议的工作
为了建立病理流动与促栓性表型之间的联系,高风险斑块是
形成。拟议的研究具有创新性,因为它将提出一个新的概念病理流动如何影响
内皮并诱导脆弱的侵蚀颗粒的形成,并将提供新的见解
负责该病理的信号传导级联反应和分子。拟议的研究也可能提供
预测和预防高风险斑块形成的手段。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jun-Ichi Abe其他文献
Jun-Ichi Abe的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jun-Ichi Abe', 18)}}的其他基金
Premature aging disorders, metabolites, and atherosclerosis
过早衰老疾病、代谢产物和动脉粥样硬化
- 批准号:
10607893 - 财政年份:2022
- 资助金额:
$ 79.39万 - 项目类别:
Mitigating radiation-induced cardiovascular disease by inhibiting premature aging
通过抑制过早衰老减轻辐射诱发的心血管疾病
- 批准号:
10425386 - 财政年份:2020
- 资助金额:
$ 79.39万 - 项目类别:
Mitigating radiation-induced cardiovascular disease by inhibiting premature aging
通过抑制过早衰老减轻辐射诱发的心血管疾病
- 批准号:
10661520 - 财政年份:2020
- 资助金额:
$ 79.39万 - 项目类别:
Mitigating radiation-induced cardiovascular disease by inhibiting premature aging
通过抑制过早衰老减轻辐射诱发的心血管疾病
- 批准号:
10206042 - 财政年份:2020
- 资助金额:
$ 79.39万 - 项目类别:
Pathological flow-induced endothelial damage and plaque erosion
病理性血流诱导的内皮损伤和斑块侵蚀
- 批准号:
10201742 - 财政年份:2019
- 资助金额:
$ 79.39万 - 项目类别:
Pathological flow-induced endothelial damage and plaque erosion
病理性血流诱导的内皮损伤和斑块侵蚀
- 批准号:
10430067 - 财政年份:2019
- 资助金额:
$ 79.39万 - 项目类别:
Disturbed flow-induced TERF2IP post-translational modifications and atherosclerosis.
血流紊乱诱导的 TERF2IP 翻译后修饰和动脉粥样硬化。
- 批准号:
9207134 - 财政年份:2016
- 资助金额:
$ 79.39万 - 项目类别:
Disturbed flow-induced TERF2IP post-translational modifications and atherosclerosis.
血流紊乱诱导的 TERF2IP 翻译后修饰和动脉粥样硬化。
- 批准号:
9006224 - 财政年份:2016
- 资助金额:
$ 79.39万 - 项目类别:
PAR 13-233 cART accelerates vascular aging in HIV infected subjects
PAR 13-233 cART 加速 HIV 感染者的血管老化
- 批准号:
9066206 - 财政年份:2014
- 资助金额:
$ 79.39万 - 项目类别:
PAR 13-233 cART accelerates vascular aging in HIV infected subjects
PAR 13-233 cART 加速 HIV 感染者的血管老化
- 批准号:
8846422 - 财政年份:2014
- 资助金额:
$ 79.39万 - 项目类别:
相似国自然基金
长期使用鼻用糖皮质激素在变应性鼻炎中对嗅觉功能影响的病理机制研究和临床初探
- 批准号:81670904
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
大鼠胚胎Leydig细胞提早凋亡致成年细胞异常发育机理与邻苯二甲酸酯的影响
- 批准号:81601264
- 批准年份:2016
- 资助金额:17.5 万元
- 项目类别:青年科学基金项目
复方聪耳胶囊及其拆方干预离体和在体AmAn中毒性耳蜗神经细胞凋亡形态学及相关因子影响机制研究
- 批准号:81373700
- 批准年份:2013
- 资助金额:65.0 万元
- 项目类别:面上项目
体内凋亡信号分子与常用牙科合金影响机体的关系研究
- 批准号:81371174
- 批准年份:2013
- 资助金额:16.0 万元
- 项目类别:面上项目
裸鼠人类肥大乳房模型的建立及相关因素对其增殖分化和凋亡的影响
- 批准号:30973134
- 批准年份:2009
- 资助金额:26.0 万元
- 项目类别:面上项目
相似海外基金
Preclinical Development of a Novel Therapeutic Agent for Idiopathic Pulmonary Fibrosis
特发性肺纤维化新型治疗剂的临床前开发
- 批准号:
10696538 - 财政年份:2023
- 资助金额:
$ 79.39万 - 项目类别:
The Role of Glycosyl Ceramides in Heart Failure and Recovery
糖基神经酰胺在心力衰竭和恢复中的作用
- 批准号:
10644874 - 财政年份:2023
- 资助金额:
$ 79.39万 - 项目类别:
Resident Memory T cells in Chronic Kidney Disease
慢性肾脏病中的常驻记忆 T 细胞
- 批准号:
10676628 - 财政年份:2023
- 资助金额:
$ 79.39万 - 项目类别:
Investigating the role of CSF production and circulation in aging and Alzheimer's disease
研究脑脊液产生和循环在衰老和阿尔茨海默病中的作用
- 批准号:
10717111 - 财政年份:2023
- 资助金额:
$ 79.39万 - 项目类别: